Metraipolis › archive › dc_d37e7c99ec73
NIR Ratiometric Fluorescent Antibody-Drug Conjugate for Metastatic Ovarian Cancer Theranostics and Treatment Response Monitoring — Europe PMC PMID:41313802
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41313802
- DOI
- 10.1002/advs.202516607
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T04:14:43.776Z
- SHA-256 of the archived text
11e1a6a59bde0027bd110a06c0dd623bf619da54f9155eb36f5940189e3b6127- Stable URL of this page
https://metraipolis.com/documento/dc_d37e7c99ec73
How to cite
NIR Ratiometric Fluorescent Antibody-Drug Conjugate for Metastatic Ovarian Cancer Theranostics and Treatment Response Monitoring — Europe PMC PMID:41313802 — Europe PMC (en), https://europepmc.org/article/MED/41313802 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d37e7c99ec73 (Metraipolis archive dc_d37e7c99ec73, sha256 11e1a6a59bde0027bd110a06c0dd623bf619da54f9155eb36f5940189e3b6127)
BibTeX
@misc{dcd37e7c99ec73,
title = {NIR Ratiometric Fluorescent Antibody-Drug Conjugate for Metastatic Ovarian Cancer Theranostics and Treatment Response Monitoring — Europe PMC PMID:41313802},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41313802},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d37e7c99ec73; sha256 11e1a6a59bde0027bd110a06c0dd623bf619da54f9155eb36f5940189e3b6127},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41313802. Agents can read the archived copy with the MCP tool read_document.